- Report
- March 2025
- 187 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- March 2025
- 194 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- February 2024
- 137 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- September 2022
- 117 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- July 2024
- 228 Pages
Global
From €2524EUR$2,655USD£2,120GBP
- Report
- December 2023
- 228 Pages
Global
From €3394EUR$3,570USD£2,851GBP
The Acute Ischemic Stroke Diagnosis market is a subset of the Diagnostics industry. It focuses on the diagnosis of acute ischemic stroke, a medical condition caused by a lack of blood flow to the brain. Diagnostic tests used to detect this condition include computed tomography (CT) scans, magnetic resonance imaging (MRI) scans, and ultrasound. These tests are used to identify the location and extent of the stroke, as well as to determine the best course of treatment.
The Acute Ischemic Stroke Diagnosis market is highly competitive, with a number of companies offering diagnostic tests and services. Some of the major players in this market include Siemens Healthineers, Philips Healthcare, GE Healthcare, Toshiba Medical Systems, Hitachi Medical Systems, and Shimadzu Corporation. Show Less Read more